International Pharmaceutical Aerosol Consortium

IPAC

The International Pharmaceutical Aerosol Consortium (IPAC) was formed in 1989 in response to the mandates of the Montreal Protocol on Substances that Deplete the Ozone Layer and fully supported a timely and effective transition away from chlorofluorocarbons (CFCs) used in pressurised metered dose inhalers (pMDIs) under the Montreal Protocol that balanced patient health and environmental concerns.

Links

Website Transparency Register Profile

ID: 602537137644-70

Lobbying Activity

Response to COMMISSION IMPLEMENTING REGULATION (EU) …/... laying down rules for the application of Regulation (EU) 2024/573 of the European Parliament and of the Council as regards the format of the labels for certain products and equipment containing fluorinated greenhouse gases and repealing Commission Implementing Regulation (EU) 2015/2068

3 Jun 2024

Response to Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on fluorinated greenhouse gases, amending Directive (EU) 2019/1937 and repealing Regulation (EU) No 517/2014

24 Jun 2022

Meeting with Caroline Boeshertz (Cabinet of Executive Vice-President Valdis Dombrovskis)

9 Nov 2021 · Fluorinated Gases regulation

Response to Proposal for a Regulation on fluorinated greenhouse gases (recast)

5 Sept 2020